CARL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Carlsmed Inc (CARL) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock is showing bearish technical indicators, no significant trading signals, and lacks recent positive news or catalysts. While analysts maintain a Buy rating, the lowered price targets and lack of financial data or congressional trading activity make it prudent to hold off on investing right now.
The MACD is negatively expanding (-0.17), indicating bearish momentum. The RSI is neutral at 27.263, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 9.853, with resistance at 11.924. Overall, technical indicators suggest a bearish trend.
Analysts maintain a Buy rating, citing faster top-line growth and higher gross margins compared to peers.
Lowered price targets by analysts (Truist: $18 from $20, BTIG: $23 from $24). No recent news, no significant hedge fund or insider trading trends, and no congressional trading data. Bearish technical indicators and lack of financial performance data.
No financial data available for the latest quarter.
Analysts maintain a Buy rating but have lowered price targets. Truist lowered the target to $18 (from $20), and BTIG lowered it to $23 (from $24). Analysts cite strong fundamentals but acknowledge anxious investor sentiment and external factors like CMS rules impacting the sector.
